University of Queensland researchers have found a range of commonly prescribed antidepressants can increase bacteria’s resistance to antibiotic medications. A study led by Professor Jianhua Guo from UQ’s Australian Centre for Water and Environmental Biotechnology focused on prescription drugs used to treat depressive disorders, anxiety disorders, and other psychological conditions. More than 42 million prescriptions […]
Read More… from Common antidepressants can increase antibiotic resistance
Researchers have found that the drug rilmenidine can extend lifespan and slow ageing. Published in Aging Cell, the findings show that animals treated with rilmenidine, currently used to treat hypertension, at young and older ages increases lifespan and improves health markers, mimicking the effects of caloric restriction. They also demonstrate that the healthspan and lifespan […]
A drug in development for obstructive sleep apnoea (OSA) has shown promising results, after researchers from Flinders University tested the treatment in people for the first time. Designed to prevent the narrowing or collapse of the upper airways during sleep, a key factor in OSA, the treatment could prove to be a potential alternative for […]
Read More… from Could a nasal spray treat obstructive sleep apnoea?
A new trial will test whether a medication that targets gut bacteria can also improve irritability in teenagers with autism spectrum disorder (ASD). The Tapestry study, a collaboration between the Murdoch Children’s, Queensland Children’s Hospital, University of Sydney, Southern Adelaide Local Health Network and Flinders University is recruiting adolescents, aged 13-17, in Melbourne, with moderate […]
NHS winter crisis won’t be solved by pharmacies: Pharmacists pour cold water on ‘Government plans to use them during NHS strikes’. Steve Anderson, group managing director PHOENIX UK, which supports over 4,000 pharmacies in England – one in three of all pharmacies – through its Numark business, responds to the news that the Government has […]
Read More… from NHS winter crisis won’t be solved by pharmacies
The first potent COQ8 inhibitor targets ubiquinone biosynthesis: Inhibition of the COQ8 protein could be beneficial in the treatment of diseases such as cancer. COQ8 is needed for the biosynthesis of coenzyme Q, also known as ubiquinone. A new collaborative study from the University of Eastern Finland, Washington University in St. Louis, University of Wisconsin–Madison, University […]
Read More… from The first potent COQ8 inhibitor targets ubiquinone biosynthesis
Exeter awarded £14 million for antimicrobial resistance research to fight “next global pandemic” The University of Exeter and collaborators have recently been awarded £14 million for antimicrobial resistance (AMR) research – widely acknowledged as the “next global pandemic” AMR occurs when bacteria, viruses, fungi and parasites evolve to become resistant to commonly used antimicrobial drugs […]
Read More… from Exeter awarded £14 million to fight “next global pandemic”
New bid to ‘outflank’ antimicrobial resistance: A major new project will investigate the defence mechanisms of bacterial cells, to help stop the spread of drug-resistant genes. Resistance to antibiotics (known as antimicrobial resistance) is a growing problem, identified by the World Health Organisation as a top ten threat facing humanity. The new project, led by […]
Read More… from New bid to ‘outflank’ antimicrobial resistance
Positive results for concussion treatment trial: Oxeia Biopharmaceuticals Inc., a clinical stage biotech company developing a drug treatment for concussion to address underlying neuro-metabolic dysfunction and axonal injury, announced today the completion of an interim analysis of its ongoing Phase 2 clinical trial of OXE103 at the University of Kansas Medical Center. The interim results […]
Read More… from Positive results for concussion treatment trial
Medicinal cannabis study into easing symptoms of children in palliative care: A pilot study will explore the use of medicinal cannabis to reduce symptoms in children and adolescents who are undergoing palliative care for non-cancerous conditions. The study has received $75,000 from the latest round of the State Government’s Victorian Medical Research Acceleration Fund (VMRAF) […]
Read More… from Medicinal cannabis study for children in palliative care